Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-5,358
Closed -$228K 1257
2016
Q4
$228K Buy
5,358
+542
+11% +$23K ﹤0.01% 1406
2016
Q3
$228K Buy
4,816
+336
+8% +$16.8K ﹤0.01% 1367
2016
Q2
$226K Buy
4,480
+246
+6% +$12.4K ﹤0.01% 1322
2016
Q1
$204K Buy
+4,234
New +$163K ﹤0.01% 1337

Other funds holding AMED

Suntrust Banks's AMED Position: Q1 2017 in Review

Suntrust Banks sold out of Amedisys (AMED) in Q1 2017, closing a stake of 5,358 shares — an estimated $228K sold.

Suntrust Banks first reported a position in AMED in Q1 2016 and held it in 4 quarters. The position peaked at $228K in Q4 2016. 152 funds tracked by Wall St. Rank hold AMED as of Q1 2017.

  • Suntrust Banks reported no remaining Amedisys position as of Q1 2017 after selling out during the quarter.
  • Suntrust Banks sold 5,358 Amedisys shares in Q1 2017, an estimated $228K.
  • Suntrust Banks first reported a position in Amedisys in Q1 2016 and held it in 4 quarters.
  • Suntrust Banks's Amedisys position peaked at $228K in Q4 2016.
  • 152 funds tracked by Wall St. Rank held Amedisys as of Q1 2017.

Based on Suntrust Banks's 13F filing for Q1 2017, filed 3 May 2017.